BioPlus Specialty Pharmacy Launches RxExpress
ALTAMONTE SPRINGS, Fla. (PRWEB) January 08, 2018 -- BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, is excited to introduce a new program called RxExpress which will make BioPlus faster than most other pharmacies. BioPlus’ commitment to providing medications quickly led to the creation of the RxExpress process, which fine-tunes the efficiency systems in place at BioPlus from start to finish.
“Getting medications to patients quickly is a high priority for the health care providers we work with, which is why we are launching RxExpress,” shares Stephen Vogt, Pharm.D., President and CEO of BioPlus Specialty Pharmacy. “By keeping the wait time for medications as short as possible, patients don’t have to wait to get back to living their lives,” he adds.
It all begins with BioPlus’ 2-Hour Patient Acceptance Guarantee which ensures notification to physician offices in less than two hours whether their referred patients are accepted for treatment through our specialty pharmacy. This guarantee expedites communication back to the medical practice to let them know if their patients can be admitted pending insurance qualifications or are non-admitted and referred to another pharmacy.
After the 2-Hour Patient Acceptance Guarantee, oncology and rheumatoid arthritis/dermatology prescriptions move on to a new program at BioPlus called 2-Day Ready 2 Ship, which promises to have qualifying prescriptions ready to ship to patients in just two days. With 2-Day Ready 2 Ship, most prescriptions (pending appeals and prior authorizations) can be shipped with an express two day program which will then be delivered via free overnight shipping. The 2-Day Ready 2 Ship makes BioPlus five times faster than most other pharmacies.
Throughout the RxExpress process, the patient financial assistance department is hard at work with expedited financial assistance to ensure that financial issues don’t stand in the way of patient treatment. In 2017 (Q1-Q3), our financial department connected oncology patients with $30 million in patient assistance, in the form of grants, co-pay assistance, and donations.
“We know how important it is to get medications in the hands of patients without unnecessary delays, which is why the RxExpress program was established to move a prescription through our system in the most streamline way. From the 2-Hour Patient Acceptance Guarantee at the beginning to the 2-Day Ready 2 Ship (for oncology and rheumatoid arthritis/dermatology) at the end along with expedited financial assistance and free overnight shipping, physicians and patients can trust BioPlus to provide fast service. However, it’s not just about speed; more importantly it’s about effective service that’s delivered fast,” explains Elvin Montanez, Pharm.D., Chief Operations Officer at BioPlus.
A commitment by BioPlus to fast deliveries shows in our #1 ranking in patient satisfaction of independent specialty pharmacies that BioPlus earned in the recent Specialty Pharmacy Patient Satisfaction Survey (Quarter 1, 2017) conducted by Zitter Health Insights.
About BioPlus Specialty Pharmacy
BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 28 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for hepatitis C, cancer, multiple sclerosis, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.
Denise Houston, BioPlus Specialty Pharmacy, http://www.bioplusrx.com, +1 407-830-8820 Ext: 4275, [email protected]
Share this article